---
title: Submit Your Abstract for xMAP® Connect Houston
description: Register today to join Luminex at xMAP Connect 2024 in Houston, TX. Be sure to submit an abstract to have your scientific poster presented.
---
[](https://www.diasorin.com/?hsLang=en)
### Submit Your Abstract
Share your work at xMAP® Connect in Houston on October 30, 2024
Deadline: September 27, 2024
Abstract submission guidelines
Abstracts should include all of the items listed below and are limited to 3,000 characters (approximately 500 words), not including spaces:
- A title
- The author(s) and institution(s) involved
- An introductory sentence indicating the purpose(s) of the study
- A brief description of experimental methods or procedures
- A summary of your new or unpublished data
- A sentence about the conclusion(s)
- A statement about which xMAP® product(s) your study/method used and why you used them
The deadline to submit your abstract is September 27, 2024. If you have any questions about submissions or the event, email Luminex LTG Marketing at [LTG-Marketing@luminexcorp.com](mailto:LTG-Marketing@luminexcorp.com).
Accepted abstracts will be eligible for the poster competition, offering first, second, and third place awards. Voting will take place during the event and winners will be announced at the end of the sessions. Don't miss your opportunity to have your work recognized!
See contest Rules & Regulations [here](https://info.diasorin.com/hubfs/xMAP-Connect-Houston-2024-Poster-Competition-Rules-FINAL.pdf?hsLang=en).
Register for xMAP® Connect events and browse on-demand presentations and posters from past events [here](https://support.diasorin.com/luminex-xmap-connect/).
---
Agreement Upon Submission
By submitting an abstract, you agree to the following terms and conditions:
I agree to present a poster describing this work at xMAP Connect 2024 in Houston if my abstract is selected. This submission has been approved by all authors and serves to grant Luminex an irrevocable license to use the abstract and poster in connection with the xMAP Connect meeting. The author(s) accept sole responsibility for the statements in their abstracts and posters. The author(s) warrant this content is their own and is 100% original work; is not subject to, and does not infringe upon, the rights of any third parties, including without limitation privacy or publicity rights; and is not derogatory, obscene, or otherwise illegal.
### Submit Now!
[](https://us.diasorin.com/en)
**Follow us**
.
**Group**
[Company](https://us.diasorin.com/en/company)
[Sustainability](https://us.diasorin.com/en/sustainability)
[Investors](https://us.diasorin.com/en/investors)
[Careers](https://us.diasorin.com/en/careers)
[Newsroom](https://us.diasorin.com/en/newsroom)
**Our Solutions**
[Immunodiagnostics](https://us.diasorin.com/en/immunodiagnostics)
[Molecular Diagnostics](https://us.diasorin.com/en/molecular-diagnostics)
[Luminex LTG](https://us.diasorin.com/en/licensed-technologies)
**Useful Links**
[Contact us](https://us.diasorin.com/en/contact-us)
[Diasorin worldwide](https://us.diasorin.com/en/company/diasorin-worldwide)
[Immuno products Catalog](https://catalog.diasorin.com/en/disclaimer)
[My Luminex](https://luminexcorp.my.site.com/CustomerCenter/s/login/?ec=302&startURL=/CustomerCenter/s/)
[Service and support](https://us.diasorin.com/en/service-support)
**Informatives**
[Legal notice](https://us.diasorin.com/en/legal-notices)
[Privacy policy](https://us.diasorin.com/en/diasorin-global-privacy-policy)
[Modern slavery statement](https://us.diasorin.com/sites/default/files/2023-06/2022_modern_slavery_statement_0.pdf)
[Accessibility](https://int.diasorin.com/en/accessibility)
**Document Repository**
Diasorin Immuno and Molecular product documentation[](https://assayinfo.diasorin.com/login)
Licensed Technologies and Luminex products[](https://us.diasorin.com/en/product-documents-manuals)
